Michael Kearns

614 total citations · 1 hit paper
5 papers, 444 citations indexed

About

Michael Kearns is a scholar working on Oncology, Reproductive Medicine and Infectious Diseases. According to data from OpenAlex, Michael Kearns has authored 5 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Reproductive Medicine and 1 paper in Infectious Diseases. Recurrent topics in Michael Kearns's work include PARP inhibition in cancer therapy (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and interferon and immune responses (1 paper). Michael Kearns is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and interferon and immune responses (1 paper). Michael Kearns collaborates with scholars based in United States and Finland. Michael Kearns's co-authors include Thomas M. Roberts, Joyce F. Liu, Suzan Lazo, Roderick T. Bronson, Elizabeth H. Stover, Liya Ding, Brooke E. Howitt, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis and Qiwei Wang and has published in prestigious journals such as Clinical Cancer Research, Journal of the American Ceramic Society and Cell Reports.

In The Last Decade

Michael Kearns

5 papers receiving 437 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

2018 395 citations Liya Ding, Hye‐Jung Kim et al. Cell Reports profile →

Peers

Michael Kearns

ONCOL

IMMUN

MB

RM

MC

Mahdieh Shokrollahi Barough Iran

Elfriede Nößner Germany

Marta Pires de Miranda Portugal

Kathy Matuszewska Canada

Diana Lim Singapore

Seungwon Lee South Korea

Chungyong Han South Korea

Firas Hamdan Finland

Amagoia Ametzazurra Spain

Mahdieh Shokrollahi Barough Iran

Michael Kearns

74 ×0.3

ONCOL

112 ×0.6

IMMUN

125 ×0.8

MB

16 ×0.3

RM

17 ×0.5

MC

Citations per year, relative to Michael Kearns Michael Kearns (= 1×) peers Mahdieh Shokrollahi Barough

Countries citing papers authored by Michael Kearns

Since Specialization

Citations

This map shows the geographic impact of Michael Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kearns more than expected).

Fields of papers citing papers by Michael Kearns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kearns. The network helps show where Michael Kearns may publish in the future.

Co-authorship network of co-authors of Michael Kearns

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kearns. A scholar is included among the top collaborators of Michael Kearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kearns. Michael Kearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ding, Liya, Qiwei Wang, Antons Martincuks, et al.. (2022). 910 STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Regular and Young Investigator Award Abstracts. A948–A948. 3 indexed citations

2.

Ding, Liya, Qiwei Wang, Michael Kearns, et al.. (2020). Abstract IA17: PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor. Clinical Cancer Research. 26(13_Supplement). IA17–IA17. 1 indexed citations

3.

Ding, Liya, Hye‐Jung Kim, Qiwei Wang, et al.. (2018). PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Reports. 25(11). 2972–2980.e5. 395 indexed citations breakdown →

4.

Kearns, Michael, et al.. (1995). Corporate Diplomacy: Principled Leadership for the Global Community. Medical Entomology and Zoology. 2 indexed citations

5.

Ruh, Robert, Michael Kearns, Avigdor Zangvil, & Youren Xu. (1992). Phase and Property Studies of Boron Carbide–Boron Nitride Composites. Journal of the American Ceramic Society. 75(4). 864–872. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact